Clinical trials: Art Therapy
HIV Infections
A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy
The purpose of this clinical research study is to learn if atazanavir is associated with serum LDL cholesterol in HIV-infected subjects following a substitution of atazanavir for their previously administered protease inhibitor.
- Trial name
- NCT00067782
- Testing
- Atazanavir (immediate switch), Atazanavir (Week 24 switch)
- Where
- 19 sites in United States
- Sponsor
- Bristol-Myers Squibb